Calderon, Rufo .
HRN: 07-60-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2023
CLOXACILLIN 500MG (CAP)
11/05/2023
11/11/2023
PO
500mg
Q6
R/O Tetanus; Punctured Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes